News & Insights

2026-04-16

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing

Read more
2026-03-31

NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody–Drug Conjugate Development

Read more
2025-11-17

Ajinomoto Bio-Pharma Services Wins “Best ADC Preclinical Publication 2024” Award for AJICAP® Technology at 2025 World ADC Awards

Read more
2025-10-28

Ajinomoto Bio-Pharma Services and Olon S.p.A. Form Strategic Partnership to Advance Large-Scale Peptide and Protein Manufacturing

Read more
2025-05-06

Successful Extension of Nucleic Acid Aptamer Pharmacokinetics in Joint Research by Ajinomoto Co., Inc. and RIBOMIC Inc.

Read more
2025-04-24

Ajinomoto Co., Inc. to Sell* its Entire Equity Stake in Ajinomoto Althea, a US-based Aseptic Fill/Finish CDMO (*Completed on May 1, 2025)

Read more
2025-03-20

Ajinomoto Bio-Pharma Services Awarded CDMO Leadership Awards

Read more
2024-09-05

Leading Global CDMO Ajinomoto Bio-Pharma Services Joins CMAC as New Translation to Industry Collaborator

Read more
2024-06-12

Ajinomoto Bio-Pharma Services Announces the Approval of the 32nd Drug Product at their San Diego Sterile Fill Finish Site

Read more
2024-03-12

Ajinomoto Bio-Pharma Services Garners Six ‘CDMO Leadership Awards,’ Further Establishing Its Industry Excellence

Read more
2023-12-27

Notice Regarding Joint Research Agreement with RIBOMIC Inc.

Read more
2023-05-18

Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility

Read more

Loading…Load More

Genetic Engineering & Biotechnology News

CDMOs Forge Links to Next-Gen Antibody Conjugates
MJH Life Sciences

Manufacturing Materials for Clinical Trials – An Interview
MJH Life Sciences

Speeding Development and Manufacturing of Materials for Clinical Trials – An Interview
Contract Pharma

Emphasizing Sustainability in Contract Manufacturing – An Interview
Kineticos Life Sciences

Panel Discussion – Part III: CDMO Strategy in a COVID-19 World
ACS Publications

Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology
Fierce Pharma

Interview – A CDMO for the Future: Adapting Services for Evolving Needs
ACS Publications

Good Manufacturing Practice Strategy for Antibody–Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP
Contract Pharma

Contract Pharma’s 20th Anniversary Retrospective

Loading…Load More

2025-11-18

Webinar – Engineering the Future of API Manufacturing: A Scientific Approach to Continuous Flow
2024-07-03

Webinar – You Had Me At Flow: The Shift From Batch To Continuous
2024-03-13

Webinar – Breaking Bad Manufacturing Habits: Strategies For Sustainable API Production
2023-11-28

Plasmid Production: The Benefits of Working with an Experienced CDMO
2023-05-09

Strategies for Scaling HPAPI Production Webinar
2022-12-05

Sustainable Approaches to Oligonucleotide Manufacturing
2022-01-10

The Paradigm Shift to Continuous Flow Processes: A Holistic View
2021-05-12

Plasmid Manufacturing for Gene Therapies: An Outsourcing Partnership Duration
2021-01-28

Oligonucleotide Therapeutics: Bridging from Research to Commercial
2020-12-01

Operational Excellence: Crafting a Champion Out of an Athlete
2020-09-22

Webinar: Are You Protecting Your Employees During HPAPI Manufacturing